Ratings by Wells Fargo (Lawrence Biegelsen)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/1/2026 | Tandem Diabetes Care | TNDM | Upgrade | Overweight (Equal Weight) |
16.72 (15.30) |
-8.49% | Details | |
| 5/28/2026 | Boston Scientific | BSX | Downgrade | Equal Weight (Overweight) |
50.46 (45.29) |
-10.25% | Details | |
| 5/8/2026 | Becton Dickinson | BDX | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 4/23/2026 | Boston Scientific | BSX | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/13/2026 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Zimmer Biomet | ZBH | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/11/2026 | Edwards Lifesciences | EW | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/10/2026 | Becton Dickinson | BDX | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/5/2026 | GE HealthCare | GEHC | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/5/2026 | Boston Scientific | BSX | Maintain | Overweight (Overweight) |
|
Details | ||
| 1/15/2026 | Penumbra | PEN | Downgrade | Equal Weight (Overweight) |
313.43 (317.20) |
1.2% | Details | |
| 1/14/2026 | Inspire Medical Systems | INSP | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/12/2025 | Inspire Medical Systems | INSP | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/12/2025 | Tandem Diabetes Care | TNDM | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 12/5/2025 | Edwards Lifesciences | EW | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/4/2025 | Inspire Medical Systems | INSP | Upgrade | Overweight (Equal Weight) |
72.08 (68.14) |
-5.47% | Details | |
| 10/31/2025 | DexCom | DXCM | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/31/2025 | Edwards Lifesciences | EW | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/23/2025 | Boston Scientific | BSX | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/8/2025 | Becton Dickinson | BDX | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/7/2025 | Tandem Diabetes Care | TNDM | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/7/2025 | Edwards Lifesciences | EW | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/25/2025 | Edwards Lifesciences | EW | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/24/2025 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/19/2025 | RxSight Inc. | RXST | Upgrade | Overweight (Equal Weight) |
14.19 (12.43) |
-12.4% | Details | |
| 5/6/2025 | Zimmer Biomet | ZBH | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 5/6/2025 | Inspire Medical Systems | INSP | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 5/2/2025 | Becton Dickinson | BDX | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 4/7/2025 | RxSight Inc. | RXST | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 4/3/2025 | RxSight Inc. | RXST | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 3/3/2025 | Tandem Diabetes Care | TNDM | Downgrade | Equal Weight (Overweight) |
22.14 (15.30) |
-30.89% | Details | |
| 2/26/2025 | RxSight Inc. | RXST | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/14/2025 | DexCom | DXCM | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/11/2025 | Inspire Medical Systems | INSP | Maintain | (N/A) |
|
Details | ||
| 2/7/2025 | Zimmer Biomet | ZBH | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/7/2025 | Becton Dickinson | BDX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2025 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2025 | Inari Medical Inc. | NARI | Downgrade | Equal Weight (Overweight) |
65.00 (79.97) |
23.03% | Details | |
| 12/11/2024 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 12/11/2024 | RxSight Inc. | RXST | Downgrade | Equal Weight (Overweight) |
39.17 (14.19) |
-63.77% | Details | |
| 11/8/2024 | Becton Dickinson | BDX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2024 | RxSight Inc. | RXST | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2024 | Inspire Medical Systems | INSP | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/31/2024 | Zimmer Biomet | ZBH | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/25/2024 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 10/24/2024 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/10/2024 | Zimmer Biomet | ZBH | Maintain | Equal Weight (N/A) |
|
Details | ||
| 9/9/2024 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2024 | RxSight Inc. | RXST | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2024 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/31/2024 | Inari Medical Inc. | NARI | Maintain | Overweight (N/A) |
|
Details | ||
| 7/26/2024 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/25/2024 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 7/25/2024 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/9/2024 | Shockwave Medical | SWAV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/7/2024 | RxSight Inc. | RXST | Maintain | Overweight (N/A) |
|
Details | ||
| 5/3/2024 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 4/29/2024 | Tandem Diabetes Care | TNDM | Upgrade | Overweight (Equal Weight) |
35.24 (15.30) |
-56.58% | Details | |
| 4/26/2024 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 4/25/2024 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/22/2024 | Nevro Corp | NVRO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/16/2024 | Shockwave Medical | SWAV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/8/2024 | Zimmer Biomet | ZBH | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/2/2024 | Edwards Lifesciences | EW | Upgrade | Overweight (Equal Weight) |
78.71 (87.36) |
10.99% | Details | |
| 2/1/2024 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/17/2024 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/11/2024 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 1/10/2024 | Nevro Corp | NVRO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 12/13/2023 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 12/13/2023 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/13/2023 | Inspire Medical Systems | INSP | Downgrade | Equal Weight (Overweight) |
178.08 (42.61) |
-76.07% | Details | |
| 12/13/2023 | RxSight Inc. | RXST | Upgrade | Overweight (Equal Weight) |
37.53 (4.73) |
-87.4% | Details | |
| 11/10/2023 | Becton Dickinson | BDX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2023 | Zimmer Biomet | ZBH | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/7/2023 | Shockwave Medical | SWAV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/26/2023 | Edwards Lifesciences | EW | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/8/2023 | RxSight Inc. | RXST | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/8/2023 | Shockwave Medical | SWAV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/4/2023 | Tandem Diabetes Care | TNDM | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/4/2023 | Becton Dickinson | BDX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/28/2023 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/6/2023 | Nevro Corp | NVRO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 6/5/2023 | RxSight Inc. | RXST | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/10/2023 | RxSight Inc. | RXST | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/9/2023 | Shockwave Medical | SWAV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/4/2023 | Tandem Diabetes Care | TNDM | Maintain | Equal Weight (N/A) |
|
Details | ||
| 4/12/2023 | Shockwave Medical | SWAV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/8/2023 | Edwards Lifesciences | EW | Downgrade | Equal Weight (Overweight) |
78.80 (87.36) |
10.86% | Details | |
| 3/7/2023 | RxSight Inc. | RXST | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/11/2023 | Nevro Corp | NVRO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 12/12/2022 | Shockwave Medical | SWAV | Downgrade | Equal Weight (Overweight) |
230.06 (334.75) |
45.51% | Details | |
| 12/12/2022 | RxSight Inc. | RXST | Downgrade | Equal Weight (Overweight) |
13.36 (4.73) |
-64.6% | Details | |
| 12/12/2022 | Nevro Corp | NVRO | Downgrade | Equal Weight (Overweight) |
42.12 (13.29) |
-68.45% | Details | |
| 12/9/2022 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 11/23/2022 | Zimmer Biomet | ZBH | Upgrade | Equal Weight (Underweight) |
115.33 (87.97) |
-23.72% | Details | |
| 11/15/2022 | Tandem Diabetes Care | TNDM | Upgrade | Equal Weight (Underweight) |
39.53 (35.24) |
-10.85% | Details | |
| 10/28/2022 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2022 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2022 | Tandem Diabetes Care | TNDM | Downgrade | Underweight (Overweight) |
59.54 (15.30) |
-74.3% | Details | |
| 8/4/2022 | Nevro Corp | NVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2022 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/29/2022 | DexCom | DXCM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/29/2022 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 6/24/2022 | Becton Dickinson | BDX | Upgrade | Overweight (Equal Weight) |
237.27 (143.98) |
-39.32% | Details | |
| 4/1/2022 | Becton Dickinson | BDX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/24/2022 | Nevro Corp | NVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2022 | Tandem Diabetes Care | TNDM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/8/2022 | Zimmer Biomet | ZBH | Maintain | Underweight (N/A) |
|
Details | ||
| 2/4/2022 | Becton Dickinson | BDX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/19/2022 | Zimmer Biomet | ZBH | Downgrade | Underweight (Equal Weight) |
126.35 (87.97) |
-30.38% | Details | |
| 1/19/2022 | Tandem Diabetes Care | TNDM | Upgrade | Overweight (Equal Weight) |
116.23 (15.30) |
-86.84% | Details | |
| 1/19/2022 | DexCom | DXCM | Upgrade | Overweight (Equal Weight) |
429.87 (72.47) |
-83.14% | Details | |
| 12/6/2021 | Edwards Lifesciences | EW | Upgrade | Overweight (Equal Weight) |
109.82 (87.36) |
-20.45% | Details | |
| 12/6/2021 | Nevro Corp | NVRO | Upgrade | Overweight (Equal Weight) |
91.32 (5.84) |
-93.6% | Details | |
| 11/9/2021 | Nevro Corp | NVRO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/4/2021 | Tandem Diabetes Care | TNDM | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/28/2021 | Edwards Lifesciences | EW | Maintain | Equal Weight (N/A) |
|
Details | ||
| 9/23/2021 | Eargo Inc. | EAR | Downgrade | Equal Weight (Overweight) |
22.06 (2.57) |
-88.35% | Details | |
| 9/15/2021 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2021 | Becton Dickinson | BDX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/5/2021 | Nevro Corp | NVRO | Downgrade | Equal Weight (Overweight) |
151.19 (5.84) |
-96.14% | Details | |
| 8/2/2021 | Boston Scientific | BSX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2021 | Edwards Lifesciences | EW | Maintain | Equal Weight (N/A) |
|
Details | ||
| 7/30/2021 | DexCom | DXCM | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/28/2021 | DexCom | DXCM | Upgrade | Equal Weight (Underweight) |
354.69 (72.47) |
-79.57% | Details | |
| 4/30/2021 | DexCom | DXCM | Maintain | Underweight (N/A) |
|
Details | ||
| 4/21/2021 | Edwards Lifesciences | EW | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/10/2021 | Inari Medical Inc. | NARI | Maintain | Overweight (N/A) |
|
Details | ||
| 1/20/2021 | Inari Medical Inc. | NARI | Maintain | Overweight (N/A) |
|
Details | ||
| 12/15/2020 | Inari Medical Inc. | NARI | Upgrade | Overweight (Equal Weight) |
66.85 (79.97) |
19.63% | Details | |
| 12/15/2020 | Tandem Diabetes Care | TNDM | Downgrade | Underweight (Equal Weight) |
91.00 (15.30) |
-83.19% | Details | |
| 12/15/2020 | Becton Dickinson | BDX | Downgrade | Equal Weight (Overweight) |
242.69 (143.98) |
-40.67% | Details | |
| 11/18/2020 | Edwards Lifesciences | EW | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/2/2020 | DexCom | DXCM | Downgrade | Underweight (Equal Weight) |
412.23 (72.47) |
-82.42% | Details | |
| 7/24/2020 | Edwards Lifesciences | EW | Maintain | Equal Weight (N/A) |
|
Details | ||
| 4/28/2020 | Edwards Lifesciences | EW | Downgrade | Equal Weight (Overweight) |
223.48 (87.36) |
-60.91% | Details | |
| 6/26/2019 | Baxter International | BAX | Maintain | Overweight (N/A) |
|
Details |
